As of 2025-06-30, the Fair Value of Tonix Pharmaceuticals Holding Corp (TNXP) is -90.11 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 35.98 USD, the upside of Tonix Pharmaceuticals Holding Corp is -350.45%.
With the market price of 35.98 USD and our fair value calculation, Tonix Pharmaceuticals Holding Corp (TNXP) is not a good investment. Investing in TNXP stocks now will result in a potential loss of 350.45%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -50.46 | -92.29 | -110.22 | -116.66 | -130.04 | -99.93 |
| YoY growth | -76.31% | -82.90% | -19.43% | -5.84% | -11.47% | -39.19% |
| Market Cap (mil) | 263.37 |
| P/E | |
| Forward P/E |
| EPS | -18.02 |
| Avg earnings growth rate | -39.19% |
| TTM earnings | -131.93 |